Published forecasts put the 2025 pharmaceutical blister packaging machine market near USD 2.4–2.57 billion. That range supports category planning, but machine selection still depends on accepted output, format layout, barrier material, validation scope and FAT evidence.
- Two current equipment-market sources converge near USD 2.4–2.57 billion for 2025 and a 2.8% compound annual growth rate, although their definitions and methods may differ.
- Do not compare an equipment forecast with a much larger packaging-material or finished-pack market value.
- Convert annual accepted-pack demand into cards per minute, then into cycles per minute using the approved format layout.
- Request a quotation only after product, forming material, lidding material, cavity drawing, utilities, inspection and validation boundaries are defined.
For a pharmaceutical plant, a market report answers whether the equipment category is expanding. It does not answer whether a specific machine will run your tablet, capsule or medical-device format at the required quality level. This guide separates market evidence from the engineering inputs needed to specify a pharmaceutical blister packaging machine.
How Large Is the Pharmaceutical Blister Machine Market?
Published 2025 estimates for pharmaceutical blister packaging equipment sit in a relatively narrow range. The figures below are directional planning inputs, not audited industry totals.
| Published source | Reported equipment scope | Reported outlook | Buyer use |
|---|---|---|---|
| Custom Market Insights | Pharmaceutical blister packaging machines | USD 2.57 billion in 2025 to USD 3.29 billion in 2034; 2.8% CAGR | Category direction and long-range capacity context |
| Future Market Insights | Pharma blister packaging machines | USD 2.4 billion in 2025 to USD 3.2 billion in 2035; 2.8% CAGR | Second directional estimate; methodology still requires review |
Why Some Blister Market Numbers Are Much Larger
Material and finished-pack studies count recurring consumption of PVC, PVDC, PCTFE, aluminum and related packaging components. Equipment studies count machinery revenue. A packaging-material market can therefore be several times larger than the machine market without contradicting it.
The practical rule is simple: use equipment-market data to discuss supplier capacity and machinery investment trends. Use barrier-material studies to evaluate supply, sustainability and pack-performance risks. Neither replaces stability data for the actual product and container-closure system.
Convert Annual Demand into a Defensible Machine Rate
Rated speed is frequently quoted without stating whether it means cycles, cards or product units per minute. That ambiguity can create an undersized line or an unrealistic FAT target. Start with accepted annual demand and work backwards.
A plant needs 60,000,000 accepted blister cards per year. It plans 300 production days, two 8-hour shifts per day and 75% overall equipment effectiveness.
Scheduled hours = 300 × 2 × 8 = 4,800 hours/year Required accepted rate = 60,000,000 ÷ (4,800 × 60 × 0.75) = 277.8 cards/min At 4 cards per cycle: 277.8 ÷ 4 = 69.4 cycles/min With 20% engineering headroom: 69.4 × 1.20 = 83.3 cycles/minThe example is not a universal sizing rule. Change the demand, shifts, OEE, cards per cycle and headroom to match the project. The FAT must test the named product-material-format combination.
One verified HIJ DPH-380B project specification lists 40–180 cycles per minute, a 40–240 mm feed stroke, a maximum forming area of 260 × 240 mm and a maximum forming depth of 14 mm. Those values describe that platform file, not every blister machine. The cards-per-minute result still depends on how many approved cards fit each tool cycle.
Buyers comparing platforms should review the blister machine speed guide and send actual product and pack drawings before treating catalogue speed as accepted output.
Five Inputs That Matter More Than the Market CAGR
1. Product and cavity geometry
Record product dimensions, tolerances, weight, friability, coating, orientation and feeding behavior. A tablet that bridges in a track or a capsule that changes orientation can limit output before the forming and sealing stations reach their mechanical rate.
2. Forming and lidding structure
PVC/Aluminum, PVC-PVDC/Aluminum and cold-form Aluminum/Aluminum packs have different barrier, forming, heating, web-tension and tooling requirements. The final selection should follow product stability and packaging-development evidence. The forming-material guide explains the machine-side differences.
3. Format range and changeover
List every approved card drawing, cavity pitch, index length and batch size. A broad theoretical format range is less useful than documented tooling, recipe control, cleaning access and repeatable changeover for the formats actually purchased. Review the tooling and format-change guide before defining the URS.
4. Inspection, rejection and data
Define missing-product detection, print inspection, batch coding, reject confirmation, audit records and line-stop behavior. State whether rejected cards are included in the quoted rate. A supplier cannot design a defensible control boundary from the phrase “vision system required.”
5. Qualification evidence
The FDA’s container-closure guidance explains that suitability must be shown for the intended use and that acceptance criteria should be based on data for the specific product and packaging system. WHO’s stability guidance outlines the stability-data package for APIs and finished products. The machine supplier supports the evidence package; the manufacturer remains responsible for product approval and validation decisions.
From Market Forecast to URS and FAT
- Use the market forecast as context. Record the source and scope; do not copy its CAGR into the machine acceptance criteria.
- Calculate accepted capacity. Use annual demand, scheduled hours, OEE, cards per cycle and an explicit engineering margin.
- Freeze the test matrix. Name the products, materials, tools, utilities and operators needed for the FAT.
- Define pass/fail evidence. Include sustained output, reject challenges, seal-quality checks, alarms, recovery, recipes and document delivery.
- Control changes. New material gauges, coatings, cavity drawings and inspection systems require impact assessment before approval.
A market report can justify why a plant should review blister capacity, but it cannot determine what to buy. The DPH-380B range of 40–180 is cycles per minute—not a universal cards-per-minute promise. Tool layout determines cards per cycle, while product feeding, material behavior, inspection and rejects determine accepted output. I would request the cavity drawing, annual demand, shift pattern and material structure before discussing the final machine rate.
Basis: procurement interpretation of HIJ’s verified DPH-380B project specification. This is engineering guidance, not a customer result or market-wide performance claim.
What to Send a Blister Machine Supplier
- Product drawings, samples, tolerance range and feeding orientation.
- Finished blister-card drawing with cavity pitch, index length and perforation requirements.
- Forming web, lidding foil, thickness range, reel dimensions and approved suppliers.
- Annual accepted demand, shifts, batch sizes, planned OEE and future SKU list.
- Required coding, inspection, rejection, data, audit and line-integration functions.
- Utilities and environmental conditions at the installation site.
- URS, document language, FAT protocol, qualification support and training scope.
For early-stage terminology and process boundaries, read what a blister packaging machine does. For project execution, review HIJ’s IQ/OQ/PQ validation support page and turnkey packaging-line scope.
Frequently Asked Questions
What was the pharmaceutical blister packaging machine market size in 2025?
Does market growth mean a plant should buy a higher-speed machine?
What is the difference between cycles per minute and cards per minute?
Should PVC/Aluminum and Aluminum/Aluminum use the same equipment assumption?
What evidence should be included in a blister machine FAT?
Sources and Evidence Boundaries
- Custom Market Insights: Pharmaceutical Blister Packaging Machine Market — equipment-market estimate and forecast.
- Future Market Insights: Pharma Blister Packaging Machines Market — second equipment-market estimate and forecast.
- U.S. FDA: Container Closure Systems for Packaging Human Drugs and Biologics — suitability and data expectations for the specific product-packaging system.
- WHO TRS 1010, Annex 10 — stability-data guidance.
- HIJ internal source: verified DPH-380B technical project file. Model values are labeled as platform-specific and are not presented as market-wide benchmarks.
Turn Your Demand Plan into a Blister-Line URS
Send your product, finished pack drawing, material structure, annual demand and validation scope. HIJ will review the required forming area, tool layout, accepted rate and line boundary before preparing a project quotation.
Request Project Review & Quote







